Feedback / Questions
antolimab (AK002) - Allakos
http://www.globenewswire.com/news-release/2020/05/11/2031058/0/en/Allakos-Announces-a-Presentation-of-Antolimab-in-Patients-with-Severe-Allergic-Conjunctivitis-at-the-2020-ASCRS-Virtual-Annual-Meeting.html
May 11, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next